BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
FRSX
Foresight Autonomous Holdings Ltd.
There isn't enough reported data to score FRSX yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
FRSX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
FRSX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | โ |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
FRSX PE Valuation
FRSX has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
FRSX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| -- | |
| Limited | |
| High |
Analysts expect FRSX's losses to grow, with revenue declining.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over FRSX in the latest year-over-year earnings comparison.
FRSX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$0.50 | +$0.35 |
| Q4 2024 | -$0.50 | +$0.76 |
| Q2 2024 | -$0.85 | +$3.50 |
| Q4 2023 | -$1.26 | +$7.20 |
| Q2 2023 | -$4.35 | +$3.33 |
| Q4 2022 | -$8.46 | -$3.00 |
| Q2 2022 | -$7.68 | -$1.38 |
| Q4 2021 | -$5.46 | +$3.36 |
FRSX is still losing money, but far less than before: $0.50 per share over the past year, against $21.42 at its worst in late 2017.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over FRSX in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
FRSX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $158K | -25% |
| Q2 2025 | $240K | +7.1% |
| Q4 2024 | $212K | -52% |
| Q2 2024 | $224K | +307% |
| Q4 2023 | $442K | +46% |
| Q2 2023 | $55K | -78% |
FRSX's revenue has slid since its 2023 peak: $158,000 last quarter, down 64% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -3789% | -2138 points |
| Q2 2025 | -2581% | +13775 points |
| Q4 2024 | -3097% | -172 points |
| Q2 2024 | -2728% | +749 points |
| Q4 2023 | -1650% | N/A |
| Q2 2023 | -16356% | N/A |
| Q4 2022 | -2925% | N/A |
| Q2 2022 | -3476% | N/A |
FRSX's operating margin was โ3789% last quarter, down 2138 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: โ$11.6B over the past year.
FRSX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$5.1M | +$859K |
| Q2 2025 | -$5.4M | -$220K |
| Q4 2024 | -$6M | +$1M |
| Q2 2024 | -$5.2M | +$2.9M |
| Q4 2021 | -$6.5M | -$776K |
| Q2 2021 | -$5.8M | -$39K |
| Q4 2020 | -$5.8M | +$460K |
| Q2 2020 | -$5.8M | -$41K |
FRSX has burned cash in almost every quarter: โ$22M over the past year, against โ$27M the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
FRSX Net Leverage
FRSX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
FRSX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.9 | Oversold |
| Stochastic | 6.7 | Oversold |
FRSX's weekly RSI is 21 (oversold) and its Stochastic is 7 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
FRSX PE vs Consumer Cyclical Sector
FRSX has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
FRSX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.82 | 30% below |
| 20 week MA | $1.12 | 49% below |
| 50 week MA | $2.16 | 74% below |
| 100 week MA | $7.77 | 93% below |
| 200 week MA | $21.1 | 97% below |
FRSX is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over FRSX on returns for 2026, with the stronger performance.
FRSX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $132.3 | $632.5 | +378% |
| 2021 | $632.5 | $235.6 | -63% |
| 2022 | $235.6 | $64.3 | -73% |
| 2023 | $64.3 | $21.6 | -66% |
| 2024 | $21.6 | $38.6 | +79% |
| 2025 | $38.6 | $4.50 | -88% |
| 2026 YTD | $4.50 | $0.57 | -87% |
FRSX's yearly returns have swung widely, from +378% in 2020 to โ88% in 2025. It's down 87% so far in 2026.